Market Cap: $12.12M
LI
Lipocine Inc.
LPCN
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $12.12M
Lipocine Inc. (Ticker: LPCN) is making strides in the biopharmaceutical industry with its innovative drug candidates aimed at treating postpartum depression and other major health issues. The company…
Lipocine Inc. (NASDAQ:LPCN) experiences a challenging moment as its LPCN 1154 medication aimed at postpartum depression (PPD) fails a pivotal Phase 3 clinical trial. This setback significantly impacts…
Lipocine’s LPCN 1154: Mixed Results in Postpartum Depression Trial, But Promising Data Emerges Lipocine Inc. presents a nuanced picture following the topline results of its Phase 3 trial involving LPC…
Lipocine Advances Postpartum and Major Depressive Disorder Treatments with Innovative Therapies Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company specializing in advanced oral delivery systems…
Lipocine's LPCN 2401 Shows Promising Results in Phase 2 Trial for Metabolic Dysfunction Lipocine Inc., a biopharmaceutical company dedicated to innovative oral delivery solutions, presents compelling…
Lipocine Showcases Promising Results for LPCN 2401 at ObesityWeek® 2025 Lipocine Inc., a biopharmaceutical company specializing in oral delivery systems, recently presents significant findings on LPCN…
Lipocine's Innovative Approach to Oral Delivery in Biopharma Lipocine Inc., a biopharmaceutical company focused on innovative oral delivery systems, is poised to showcase its advancements at the H.C.…
Lipocine Advances Innovative Oral Delivery Solutions in Biopharmaceuticals Lipocine Inc., a pioneering biopharmaceutical company, is making significant strides in the development of innovative oral de…
Lipocine Advances Epilepsy Treatment with Upcoming Presentations Lipocine Inc., a biopharmaceutical company specializing in innovative oral delivery solutions, makes a significant stride in the epilep…
Lipocine Advances Epilepsy Treatment at AES Conference Lipocine Inc., a biopharmaceutical company specializing in innovative oral delivery solutions, showcases its commitment to addressing significant…